SCHEMBL13437147

SCHEMBL13437147

O=C(Cc1cccnc1)NC1c2ccccc2-c2c(-c3nc4cnccc4[nH]3)cccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 5/20 0.63
MAPT P10636 1/20 0.45
PARP14 Q460N5 1/20 0.42
SIGMAR1 Q99720 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
USP2 O75604 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CXCR3 P49682 1/20 0.38
F3 P13726 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
PSMB8 P28062 1/20 0.38
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
IDO1 P14902 2/20 0.37
TNKS O95271 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12430603 0.89 HSP90AB1 (0.58) HSP90AB1MAPTPARP14KDM4EALDH1A1
SCHEMBL12431594 0.87 HSP90AB1 (0.58) HSP90AB1MAPTPARP14KDM4EALDH1A1
SCHEMBL2314870 0.85 HSP90AB1 (0.75) HSP90AB1MAPTKDM4EALDH1A1HPGD
SCHEMBL17169737 0.84 HSP90AB1 (0.86) HSP90AB1MAPTKDM4EALDH1A1HPGD
SCHEMBL19556862 0.84 HSP90AB1 (0.71) HSP90AB1MAPTKDM4EALDH1A1HPGD
SCHEMBL25142921 0.84 HSP90AB1 (0.70) HSP90AB1MAPTKDM4EALDH1A1HPGD
SCHEMBL13437177 0.84 HSP90AB1 (0.68) HSP90AB1MAPTKDM4EALDH1A1HPGD
SCHEMBL13437148 0.84 HSP90AB1 (0.61) HSP90AB1MAPTKDM4EALDH1A1HPGD
SCHEMBL19556863 0.83 HSP90AB1 (0.69) HSP90AB1MAPTKDM4EALDH1A1HPGD
SCHEMBL19556649 0.82 HSP90AB1 (0.68) HSP90AB1MAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 HSP90AB1 2/4885MAPT 844/4885PARP14 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.